Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - COST OF REVENUE
Cost of Revenue LGVN - Longeveron Inc.
488 K
LAST VALUE
-17.44%
2 YEAR CAGR
-19.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR